Cargando…
Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
A 69‐year‐old man with non‐small cell lung cancer presenting with pericardial effusion and rapid progression of dyspnea achieved long‐term disease stabilization after radiation therapy and immunotherapy. This case shows that pembrolizumab may improve prognosis in advanced lung cancer, even when comp...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795085/ https://www.ncbi.nlm.nih.gov/pubmed/36590662 http://dx.doi.org/10.1002/ccr3.6795 |